| Phloretin prevents high-fat diet-induced obesity and improves metabolic homeostasis S Alsanea, M Gao, D Liu The AAPS journal 19, 797-805, 2017 | 66 | 2017 |
| BITC and S-Carvone Restrain High-Fat Diet-Induced Obesity and Ameliorate Hepatic Steatosis and Insulin Resistance S Alsanea, D Liu Pharmaceutical research 34, 2241-2249, 2017 | 54 | 2017 |
| Dynamics of choline-containing phospholipids in traumatic brain injury and associated comorbidities S Javaid, T Farooq, Z Rehman, A Afzal, W Ashraf, MF Rasool, F Alqahtani, ... International Journal of Molecular Sciences 22 (21), 11313, 2021 | 51 | 2021 |
| Aggravation of autism-like behavior in BTBR T+ tf/J mice by environmental pollutant, di-(2-ethylhexyl) phthalate: Role of nuclear factor erythroid 2-related factor 2 and … A Nadeem, SF Ahmad, NO Al-Harbi, SM Attia, SA Bakheet, S Alsanea, ... International Immunopharmacology 91, 107323, 2021 | 40 | 2021 |
| Exposure to the plasticizer, Di-(2-ethylhexyl) phthalate during juvenile period exacerbates autism-like behavior in adult BTBR T+ tf/J mice due to DNA hypomethylation and … A Nadeem, NO Al-Harbi, SF Ahmad, K Alhazzani, SM Attia, S Alsanea, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 109, 110249, 2021 | 37 | 2021 |
| Bruton’s tyrosine kinase inhibition attenuates oxidative stress in systemic immune cells and renal compartment during sepsis-induced acute kidney injury in mice A Nadeem, SF Ahmad, NO Al-Harbi, KE Ibrahim, F Alqahtani, WA Alanazi, ... International Immunopharmacology 90, 107123, 2021 | 36 | 2021 |
| Inhibition of tyrosine kinase signaling by tyrphostin AG126 downregulates the IL-21/IL-21R and JAK/STAT pathway in the BTBR mouse model of autism SF Ahmad, MA Ansari, A Nadeem, SA Bakheet, S Alsanea, KA Al-Hosaini, ... Neurotoxicology 77, 1-11, 2020 | 25 | 2020 |
| Physiologically-based pharmacokinetic modeling for single and multiple dosing regimens of ceftriaxone in healthy and chronic kidney disease populations: a tool for model … F Alasmari, MS Alasmari, HM Muwainea, HA Alomar, AF Alasmari, ... Frontiers in pharmacology 14, 1200828, 2023 | 19 | 2023 |
| Acetyl-11-keto-β-boswellic acid improves clinical symptoms through modulation of Nrf2 and NF-κB pathways in SJL/J mouse model of experimental autoimmune encephalomyelitis A Nadeem, SF Ahmad, NO Al-Harbi, W Sarawi, SM Attia, WA Alanazi, ... International Immunopharmacology 107, 108703, 2022 | 19 | 2022 |
| Public perception and attitude toward community pharmacists in Saudi Arabia OA Almohammed, S Alsanea Saudi Journal of Health Systems Research 1 (2), 67-74, 2021 | 18 | 2021 |
| Apremilast ameliorates carfilzomib-induced pulmonary inflammation and vascular injuries F Imam, NO Al-Harbi, MM Al-Harbi, W Qamar, K Aljerian, OM Belali, ... International Immunopharmacology 66, 260-266, 2019 | 17 | 2019 |
| The Stat3 inhibitor, S3I-201, downregulates lymphocyte activation markers, chemokine receptors, and inflammatory cytokines in the BTBR T+ Itpr3tf/J mouse model of autism SF Ahmad, MA Ansari, A Nadeem, SA Bakheet, AZ Alanazi, S Alsanea, ... Brain Research Bulletin 152, 27-34, 2019 | 16 | 2019 |
| Prevalence, knowledge and attitude toward electronic cigarette use among male health colleges students in Saudi Arabia—A cross-sectional study S Alsanea, Z Alrabiah, S Samreen, W Syed, RM Bin Khunayn, NM Al-Arifi, ... Frontiers in public health 10, 827089, 2022 | 15 | 2022 |
| Androgen deprivation therapy and depression in the prostate cancer patients: review of risk and pharmacological management A Alwhaibi, S Alsanea, B Almadi, J Al-Sabhan, FD Alosaimi The Aging Male 25 (1), 101-124, 2022 | 12 | 2022 |
| Development and evaluation of a physiologically based pharmacokinetic model of labetalol in healthy and diseased populations H Hafsa, A Zamir, MF Rasool, I Imran, H Saeed, T Ahmad, S Alsanea, ... Pharmaceutics 14 (11), 2362, 2022 | 11 | 2022 |
| Angiotensin II type 1 receptor blockade attenuates gefitinib-induced cardiac hypertrophy via adjusting angiotensin II-mediated oxidative stress and JNK/P38 MAPK pathway in a … WA Alanazi, HN Alhamami, M Alharbi, K Alhazzani, AS Alanazi, ... Saudi Pharmaceutical Journal 30 (8), 1159-1169, 2022 | 11 | 2022 |
| A national survey of attitudes and practices of physicians relating to therapeutic drug monitoring and clinical pharmacokinetic service: strategies for enhancing patient’s care … Z Alrabiah, A Alwhaibi, S Alsanea, FK Alanazi, HS Abou-Auda International Journal of General Medicine, 1513-1524, 2021 | 11 | 2021 |
| A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations MT Zahid, A Zamir, A Majeed, I Imran, S Alsanea, T Ahmad, F Alqahtani, ... Saudi Pharmaceutical Journal 31 (8), 101675, 2023 | 9 | 2023 |
| Aptamer‑based therapy for targeting key mediators of cancer metastasis Y Alhamhoom, HM As Sobeai, S Alsanea, A Alhoshani International journal of oncology 60 (6), 1-15, 2022 | 9 | 2022 |
| Knowledge and Practice of Childbearing Women in Saudi Arabia towards Folic Acid Supplement—Evidence from a Cross-Sectional Study MN Al Arifi, AM Alqahtani, AN Alotaibi, SD Babelghaith, A Alwhaibi, ... Nutrients 14 (2), 357, 2022 | 6 | 2022 |
